USask’s Vaccine and Infectious Disease Organization receives $30 million from Government of Canada

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

USask’s Vaccine and Infectious Disease Organization (VIDO) will receive $30 million in construction funding to strengthen Canada’s preparedness for emerging infectious diseases and to become Canada’s Centre for Pandemic Research. This funding for VIDO supports building a new animal housing facility and upgrading key areas to containment level 4 (CL4), the highest level of containment. VIDO has some of the most advanced high-containment research and development capacity in the world, aimed at protecting the health of Canadians and Canada’s agriculture sector. 

VIDO presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Efficiency Unleashed: AI-enabled Patient Scheduling Platform Transforms Medical Imaging
Next

Nanostics receives funding from the University of Alberta Innovation Fund to propel adoption of the ClarityDX Prostate test